ACET · Adicet Bio, Inc. · Executive Compensation
Market Cap
$89.12M
Shares
9.36M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $1,465,747 |
| Julia Maltzman | Chief Medical Officer | $1,124,803 |
| Blake Aftab | Chief Scientific Officer and Senior Vice President | $915,489 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $4,644,365 |
| Francesco Galimi | M.D., Ph.D. Former Chief Medical Officer | $1,847,772 |
| Nick Harvey | Chief Financial Officer | $1,523,426 |
| Blake Aftab | Chief Scientific Officer and Senior Vice President | $1,473,576 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $5,973,807 |
| Nick Harvey | Chief Financial Officer | $2,132,688 |
| Donald Healey | Chief Technology Officer | $2,089,460 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $3,988,018 |
| Blake Aftab | Chief Scientific Officer | $2,479,544 |
| Francesco Galimi | Chief Medical Officer | $1,989,027 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $9,756,998 |
| Nick Harvey | Chief Financial Officer | $2,379,030 |
| Francesco Galimi | Chief Medical Officer | $2,340,860 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $11,276,287 |
| Lloyd Klickstein | M.D., Ph.D.^(^ ^)^ Chief Innovation Officer | $2,897,351 |
| Francesco Galimi | Chief Technology Officer | $1,527,789 |
| Anil Singhal | Ph.D. ^(^^8)^ Chief Executive Officer | $1,404,520 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $2,778,243 |
| Anil Singhal | Ph.D. ^(^^8)^ Chief Executive Officer | $2,703,931 |
| Lloyd Klickstein | M.D., Ph.D.^(^ ^)^ Chief Innovation Officer | $2,415,323 |
| Joan Mannick | Chief Medical Officer | $1,364,863 |
| Francesco Galimi | M.D., Ph.D.^(1^ ^)^ Chief Medical Officer | $659,750 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Chen Schor | President and Chief Executive Officer | $3,094,901 |
| Joan Mannick | Chief Medical Officer | $1,452,992 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Michael Grissinger | Class II director | Appointed | 2025-04-17 |
| Carl L. Gordon | Class II member of the board of directors | Resigned | 2025-04-17 |
| Lloyd Klickstein, M.D., Ph.D. | Class III director | Appointed | 2024-08-19 |
| Michael Kauffman, M.D., Ph.D. | Class III member of the board of directors | Resigned | 2024-08-19 |
Key facts
CIK
1720580
CUSIP
007002207
13F (30d)
22 filings
22 filers
Visit website
Investor relations